E75.243 Niemann-Pick disease type D

Name of the Condition

• Niemann-Pick disease type D (ICD-10 Code: E75.243)

Summary

Niemann-Pick disease type D is a rare inherited lysosomal storage disorder characterized by the abnormal accumulation of lipids, particularly sphingomyelin, in cells. This buildup disrupts normal cellular function, affecting organs such as the liver, spleen, and nervous system. It is a subtype of Niemann-Pick disease, part of a broader group of sphingolipid metabolism disorders, and presents with variable clinical manifestations depending on the subtype.

Causes

These disorders result from genetic mutations that impair the activity of enzymes or proteins involved in lipid breakdown. The mutations lead to the buildup of specific lipids in tissues. Inheritance is typically autosomal recessive, meaning both copies of the gene must be mutated for the condition to manifest.

Risk Factors

• Family history of Niemann-Pick disease or related lysosomal storage disorders.
• Consanguineous relationships, increasing the likelihood of recessive gene mutations.
• Ethnic backgrounds with higher carrier frequencies for specific subtypes.

Symptoms

• Enlarged liver and spleen (hepatosplenomegaly).
• Progressive neurological decline, including developmental delay or regression.
• Muscle weakness, hypotonia, or spasticity.
• Seizures or abnormal eye movements.
• Loss of motor skills or speech.
• Respiratory difficulties in severe cases.

Diagnosis

Diagnosis involves a combination of clinical evaluation, laboratory tests, and genetic analysis. Clinical assessment includes reviewing symptoms and family history. Laboratory tests may measure lipid levels or enzyme activity. Genetic testing confirms mutations associated with the condition. Imaging studies, such as MRI, may assess organ involvement.

Treatment Options

Treatment focuses on managing symptoms and complications. Supportive care includes physical therapy, speech therapy, and respiratory support. Medications may address specific symptoms, such as seizures or organ dysfunction. Enzyme replacement therapy or gene therapy are under investigation but not widely available.

Prognosis and Follow-Up

Prognosis varies by subtype and severity. Type D typically has a later onset and milder neurological involvement compared to type A. Regular follow-up with specialists, including neurologists and hepatologists, is essential to monitor organ function and adjust care plans.

Complications

Complications may include progressive organ damage, respiratory failure, and severe neurological impairment. Long-term complications can affect quality of life and require ongoing medical management.

Lifestyle & Prevention

While prevention is not possible, genetic counseling is recommended for families with a history of the condition. Supportive lifestyle measures, such as maintaining a balanced diet and avoiding infections, may help manage symptoms.

When to Seek Professional Help

Seek medical attention if symptoms such as hepatosplenomegaly, neurological decline, or respiratory difficulties develop. Early diagnosis and intervention can improve outcomes.

Tips for Medical Coders

Document the specific subtype (type D) and any associated complications. Ensure clinical documentation supports the diagnosis, including genetic testing results or organ involvement details. Verify that the code aligns with the patient's clinical presentation and avoid using broader codes when subtype-specific information is available.